AnalystBook Research · Company Intelligence

Sionna Therapeutics, Inc.

SIONNasdaqCIK 0002036042

Built from Sionna Therapeutics, Inc.'s own SEC filings · updates as new filings land · every figure links to its source

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score 17.07 safe zoneOK

Latest filings

  • 8-K · Company announcement2026-06-18
  • 8-K · Company announcement2026-05-12
  • 10-Q · Quarterly report2026-05-12
  • DEF 14A · Annual proxy (pay & governance)2026-04-27
  • 8-K · Company announcement2026-03-02
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, every figure source-linked🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask anything about Sionna Therapeutics, Inc., every answer cited🔒
  • The Intelligence Brief — added when Sionna Therapeutics, Inc.'s brief passes our SEC-figure check🔒

Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.